Aio-studien-ggmbh

This study tested two different drug combinations in 93 people with advanced bile duct cancer that could not be removed by surgery. The goal was to see how long the cancer could be kept from growing. The trial compared a newer drug combo (nal-IRI with 5-FU and leucovorin) against…

This study tested a combination of three drugs (encorafenib, binimetinib, and cetuximab) given before surgery to people with a specific type of colorectal cancer that has a BRAF V600E mutation. The goal was to see how much the tumor shrank and to check for side effects. Only 2 pe…

This study tested a combination of the immunotherapy drug atezolizumab with standard chemotherapy in 70 patients with advanced small cell lung cancer who were in poor health (ECOG 2). The goal was to see if this treatment is safe and effective for this group, who often have very …